ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/03/25 | 1,313 | 1,425 | 1,304 | 1,392 | +36 | +2.7% | 5,280,700 |
2019/03/22 | 1,407 | 1,440 | 1,325 | 1,356 | -65 | -4.6% | 6,271,100 |
2019/03/20 | 1,250 | 1,526 | 1,249 | 1,421 | +195 | +15.9% | 18,249,700 |
2019/03/19 | 1,211 | 1,227 | 1,199 | 1,226 | +12 | +1% | 826,600 |
2019/03/18 | 1,176 | 1,214 | 1,174 | 1,214 | +28 | +2.4% | 929,400 |
2019/03/15 | 1,181 | 1,202 | 1,163 | 1,186 | -4 | -0.3% | 809,100 |
2019/03/14 | 1,216 | 1,229 | 1,182 | 1,190 | -25 | -2.1% | 970,500 |
2019/03/13 | 1,207 | 1,240 | 1,168 | 1,215 | +14 | +1.2% | 1,711,100 |
2019/03/12 | 1,170 | 1,206 | 1,168 | 1,201 | +44 | +3.8% | 1,427,800 |
2019/03/11 | 1,140 | 1,161 | 1,105 | 1,157 | +22 | +1.9% | 1,138,900 |
2019/03/08 | 1,136 | 1,165 | 1,116 | 1,135 | -9 | -0.8% | 1,677,000 |
2019/03/07 | 1,231 | 1,245 | 1,136 | 1,144 | -107 | -8.6% | 3,388,200 |
2019/03/06 | 1,265 | 1,267 | 1,221 | 1,251 | -4 | -0.3% | 964,500 |
2019/03/05 | 1,234 | 1,269 | 1,220 | 1,255 | +1 | +0.1% | 1,253,400 |
2019/03/04 | 1,280 | 1,286 | 1,246 | 1,254 | +4 | +0.3% | 1,189,100 |
2019/03/01 | 1,270 | 1,278 | 1,247 | 1,250 | +7 | +0.6% | 1,447,300 |
2019/02/28 | 1,307 | 1,313 | 1,242 | 1,243 | -88 | -6.6% | 2,733,900 |
2019/02/27 | 1,215 | 1,345 | 1,212 | 1,331 | +106 | +8.7% | 4,647,300 |
2019/02/26 | 1,199 | 1,288 | 1,195 | 1,225 | +30 | +2.5% | 3,436,100 |
2019/02/25 | 1,195 | 1,229 | 1,175 | 1,195 | +7 | +0.6% | 1,715,600 |
2019/02/22 | 1,181 | 1,215 | 1,171 | 1,188 | -5 | -0.4% | 1,301,400 |
2019/02/21 | 1,200 | 1,236 | 1,186 | 1,193 | +39 | +3.4% | 2,573,100 |
2019/02/20 | 1,150 | 1,174 | 1,135 | 1,154 | +21 | +1.9% | 1,309,800 |
2019/02/19 | 1,161 | 1,190 | 1,126 | 1,133 | -30 | -2.6% | 1,627,100 |
2019/02/18 | 1,150 | 1,177 | 1,138 | 1,163 | +33 | +2.9% | 1,219,300 |
2019/02/15 | 1,126 | 1,165 | 1,110 | 1,130 | -12 | -1.1% | 1,406,400 |
2019/02/14 | 1,091 | 1,149 | 1,083 | 1,142 | +44 | +4% | 1,742,800 |
2019/02/13 | 1,140 | 1,168 | 1,077 | 1,098 | +16 | +1.5% | 2,639,600 |
2019/02/12 | 1,061 | 1,140 | 1,061 | 1,082 | +45 | +4.3% | 2,462,000 |
2019/02/08 | 1,050 | 1,066 | 1,034 | 1,037 | -37 | -3.4% | 1,234,000 |
2019/02/07 | 1,100 | 1,124 | 1,058 | 1,074 | -7 | -0.6% | 2,035,400 |
2019/02/06 | 1,086 | 1,121 | 1,072 | 1,081 | +3 | +0.3% | 1,942,900 |
2019/02/05 | 1,150 | 1,155 | 1,068 | 1,078 | +11 | +1% | 3,809,700 |
2019/02/04 | 1,021 | 1,080 | 1,021 | 1,067 | +46 | +4.5% | 2,577,700 |
2019/02/01 | 1,026 | 1,047 | 1,008 | 1,021 | +8 | +0.8% | 1,994,900 |
2019/01/31 | 1,034 | 1,058 | 1,005 | 1,013 | +15 | +1.5% | 2,635,600 |
2019/01/30 | 1,040 | 1,052 | 985 | 998 | -124 | -11.1% | 5,491,800 |
2019/01/29 | 1,121 | 1,145 | 1,099 | 1,122 | -5 | -0.4% | 1,680,400 |
2019/01/28 | 1,195 | 1,202 | 1,115 | 1,127 | -60 | -5.1% | 2,332,800 |
2019/01/25 | 1,180 | 1,204 | 1,140 | 1,187 | +8 | +0.7% | 2,292,200 |
2019/01/24 | 1,209 | 1,222 | 1,175 | 1,179 | -44 | -3.6% | 2,709,700 |
2019/01/23 | 1,124 | 1,228 | 1,113 | 1,223 | +87 | +7.7% | 3,525,800 |
2019/01/22 | 1,163 | 1,192 | 1,117 | 1,136 | -30 | -2.6% | 3,110,600 |
2019/01/21 | 1,340 | 1,360 | 1,164 | 1,166 | -144 | -11% | 5,715,900 |
2019/01/18 | 1,196 | 1,310 | 1,196 | 1,310 | +116 | +9.7% | 5,010,400 |
2019/01/17 | 1,171 | 1,234 | 1,163 | 1,194 | +20 | +1.7% | 3,252,500 |
2019/01/16 | 1,190 | 1,227 | 1,161 | 1,174 | +7 | +0.6% | 3,384,600 |
2019/01/15 | 1,102 | 1,181 | 1,093 | 1,167 | +57 | +5.1% | 2,768,500 |
2019/01/11 | 1,157 | 1,187 | 1,092 | 1,110 | -47 | -4.1% | 3,824,400 |
2019/01/10 | 1,157 | 1,268 | 1,127 | 1,157 | -15 | -1.3% | 8,868,200 |
1351~
1400
件表示中 / 4943件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 125,400円 | +197.7% | - | 0.00% | 51.24倍 | 1.64倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 348,500円 | +3.0% | +27.5% | 2.30% | 22.06倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.30倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
杏林製薬 | 153,700円 | +3.2% | +4.5% | 3.38% | 17.66倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム